LGALS8 and chronic obstructive pulmonary disease: As CSE inhibits autophagosome maturation and degradation in macrophage like cells, and consequent intracellular and extracellular concentrations of galectin-8 are altered leading to the activation of pro-inflammatory signalling cascades, the galectin-8/NDP52 pathway may prove to be a novel therapeutic target in COPD.